Next Article in Journal
Natural Product-Based Pesticide Discovery: Design, Synthesis and Bioactivity Studies of N-Amino-Maleimide Derivatives
Next Article in Special Issue
N-Butanol Subfraction of Brassica Rapa L. Promotes Reactive Oxygen Species Production and Induces Apoptosis of A549 Lung Adenocarcinoma Cells via Mitochondria-Dependent Pathway
Previous Article in Journal
Phytochemicals: Target-Based Therapeutic Strategies for Diabetic Retinopathy
Previous Article in Special Issue
Anticancer Phenolics from Dryopteris fragrans (L.) Schott
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 23
Issue 7
10.3390/molecules23071520
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antiproliferative and Antimicrobial Activities of Selected Bryophytes

by
Martin Vollár
1,2,
András Gyovai
3,
Péter Szűcs
4,
István Zupkó
3,
Marianna Marschall
4,
Boglárka Csupor-Löffler
1,2,
Péter Bérdi
3,
Anikó Vecsernyés
1,
Attila Csorba
1,
Erika Liktor-Busa
1,
Edit Urbán
5 and
Dezső Csupor
1,2,*
1
Department of Pharmacognosy, Faculty of Pharmacy, University of Szeged, H-6720 Szeged, Hungary
2
Interdisciplinary Centre for Natural Products, University of Szeged, H-6720 Szeged, Hungary
3
Department of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, H-6720 Szeged, Hungary
4
Department of Botany and Plant Physiology, Institute of Biology, Eszterházy Károly University, H-3300 Eger, Hungary
5
Institute of Clinical Microbiology, Faculty of Medicine, University of Szeged, H-6720 Szeged, Hungary
*
Author to whom correspondence should be addressed.
Molecules 2018, 23(7), 1520; https://doi.org/10.3390/molecules23071520
Submission received: 28 May 2018 / Revised: 12 June 2018 / Accepted: 20 June 2018 / Published: 23 June 2018
(This article belongs to the Collection Natural Products: Anticancer Potential and Beyond)
Versions Notes

Abstract

:
One-hundred and sixty-eight aqueous and organic extracts of 42 selected bryophyte species were screened in vitro for antiproliferative activity on a panel of human gynecological cancer cell lines containing HeLa (cervix epithelial adenocarcinoma), A2780 (ovarian carcinoma), and T47D (invasive ductal breast carcinoma) cells using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and for antibacterial activity on 11 strains using the disc-diffusion method. A total of 99 extracts derived from 41 species exerted ≥25% inhibition of proliferation of at least one of the cancer cell lines at 10 μg/mL. In the cases of Brachythecium rutabulum, Encalypta streptocarpa, Climacium dendroides, Neckera besseri, Pleurozium schreberi, and Pseudoleskeella nervosa, more than one extract was active in the antiproliferative assay, whereas the highest activity was observed in the case of Paraleucobryum longifolium. From the tested families, Brachytheciaceae and Amblystegiaceae provided the highest number of antiproliferative extracts. Only 19 samples of 15 taxa showed moderate antibacterial activity, including the most active Plagiomnium cuspidatum, being active on 8 tested strains. Methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus aureus were the most susceptible to the assayed species. This is the first report on the bioactivities of these 14 species.

1. Introduction

In the era of drug development based on high-throughput pharmacological screening, there is an increasing demand for molecules to be tested. Besides large synthetic libraries, natural products are of primary importance because of their pharmacological activities and high structural diversity. In the last decades, 22% of all the newly approved drug molecules have been natural product derivatives (semisynthetic), 4% have been genuine natural products, and 13% have been made by total synthesis bearing the pharmacophore of a natural product [1]. Two of the most important research topics in drug development are anticancer agents and antibiotics. According to the World Cancer Report 2014, there were approximately 14 million new cases and 8.2 million cancer-related deaths in 2012 [2]. Although in recent years several novel strategies have been uncovered for fighting cancer, the successful treatment of several types of cancer is still a challenge, and plants continue to play a major role in drug discovery, as evidenced by the number of promising new agents in clinical development [3]. The burden of microbial infections, although most devastating in developing countries, is also increasing in Western countries as a result of spreading antibiotic resistance. Having these in mind, together with the fact that 65% of antibiotics and 35% of anticancer agents registered between 1980 and 2010 were natural products or semisynthetic derivatives thereof, the investigation of possible new sources for bioactive natural products is of primary importance.
From a phytochemical and pharmacological point of view, the most thoroughly explored taxon of the plant kingdom is vascular plants. Bryophytes (belonging to non-vascular plants) are less well studied. Although the potential presence of bioactive secondary metabolites in these species is suggested by the fact that generally bryophytes are not damaged by microorganisms, insects, or other pests [4], the phytochemistry and pharmacological profiles of the majority of species are undisclosed. The development of microscopic or genetic identification and micropropagation techniques has triggered the research into bryophytes [5].
The bryophytes, with more than 20,000 species, comprising Marchantiophyta (liverworts, ~6000 species), Bryophyta (mosses, ~14,000 species), and Anthocerotophyta (hornworts, ~300 species), can be found everywhere in the world except in the sea. In the Hungarian flora, 659 species are present, with the predominance of mosses [6]. Although not applied in human nutrition, a number of bryophytes have been widely used as medicinal plants, particularly in China for various illnesses, including for diseases of bacterial origin [7]. In other parts of the world, the medicinal use of bryophytes is rather sporadic.
The first reports on the antimicrobial effects of bryophytes date back to the 1940s. In the 1950s, the remarkable antibacterial effect of some species (Anomodon rostratus, Orthotrichum rupestre, and Plagiomnium cuspidatum) [8] attracted scientific interest, and some years later, the first extensive study on this topic, including the analysis of 50 species, was published [9]. In a comprehensive study published in 1979, the antibiotic activity of 52 species was examined on 8 bacterial strains; 56% of the tested species were active against at least one of the test bacteria [10]. Since then, several bryophytes, including the most active from the Bazzania, Conocephalum, Diplophyllum, Dumortiera, Marchantia, Metzgeria, Lunularia, Pellia, Plagiochila, Porella, Radula, and Riccardia genera, were reported to have antimicrobial activity [11,12]. In liverworts, essential oils may partly be responsible for this activity [13]; however, in several cases, active components have been identified from the involatile fraction. Sacculatal from Pellia endiviifolia showed potent antibacterial activity against Streptococcus mutans [14], lepidozenolide from Lepidozia fauriana showed activity against methicillin-resistant Staphylococcus aureus (MRSA) [15], and marchantins from many Marchantia species showed activity against more than 10 pathogen bacteria [16,17]. Herbertane sesquiterpenoids were active against Staphylococcus aureus, Klebisella pneumoniae, and Bacillus subtilis [18,19]. Chlorinated bibenzyls from Riccardia marginata exhibited antibacterial effect against Bacillus subtilis [12]. A series of diterpenoids from the liverwort Jungermannia exertifolia showed potent activity against the virulent Mycobacterium tuberculosis H37Rυ strain [20].
Extracts of several bryophytes and certain secondary metabolites exhibited remarkable in vitro cytotoxicity on cancer cell lines. Terpenoids and bibenzyl derivatives have been reported among the most potent cytotoxic compounds [21]. Sesquiterpenoids (among them, lactones), such as plagiochiline A and its derivatives [16,22], costunolide, and related compounds [23], exhibited cytotoxicity at micromolar and submicromolar concentrations. Certain diterpenes, including kaurane (e.g., rabdoumbrosanin and derivatives) [24,25], pimarane [11], and atisane-type compounds [26], were also confirmed to be active. Macrocyclic bis(bibenzyls) such as marchantins and riccardins are characteristic compounds of bryophytes. Their in vitro antiproliferative activities have been confirmed in several experiments [17,27]. The latter groups of compounds—similarly to certain kaurane diterpenes [28]—exert their effects through induction of apoptosis [29,30] and inhibit p-glycoprotein-mediated multidrug resistance [31]. Some ent-kauranes induced apoptosis through a caspase-8-dependent pathway [32,33]. In the case of diterpene jungermanenones, a caspase-independent pathway, together with the inhibition of NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells), is suggested [34]. Marchantin C, a compound with a different structure from all the previously known microtubule inhibitors, decreased the quantity of microtubules at the G2/M phase in human tumor cells and decreased the polymerisation rate of tubulin, similarly to in [30,35].
The aim of our work was to carry out an extensive in vitro bioactivity assay on 42 bryophyte species native to Hungary to identify taxa with remarkable antiproliferative and antimicrobial activities. Further, the phytochemical and bioactivity data of the assayed species were reviewed.

2. Results

In the course of the in vitro screening for antiproliferative and antimicrobial activities, 168 extracts belonging to 42 bryophyte species, 35 genera, and 20 families were evaluated using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and the disc-diffusion method, respectively. The antiproliferative activities of the extracts were assessed on human cervical (HeLa), ovarian (A2780), and breast (T47D) cancer cell lines using two final concentrations (10 and 30 µg/mL). The results of the antiproliferative assays are presented in Table 1. Extracts prepared with n-hexane (A), CHCl3 (B), aqueous MeOH (C), and H2O (D) were investigated for their cytostatic effects. A total of 98 extracts representing 41 species exerted ≥25% inhibition of proliferation of at least one of the cell lines at 10 μg/mL. The numbers of active A/B/C/D fractions were 24/38/20/16, respectively. In the case of 25 extracts (from 17 species), the inhibition was ≥50% on at least one of the cell lines at this concentration. This higher inhibition was most characteristic to B extracts (13), followed by A (7), C (4), and D (1). More than one extract was active in the case of six species, namely, Brachythecium rutabulum, Climacium dendroides, Encalypta streptocarpa, Pleurozium schreberi (A and B), Neckera besseri, and Pseudoleskeella nervosa (A, B, and C). At 30 μg/mL, 36 samples belonging to 26 species were inactive (25 of these were D extracts); further analysis of these extracts did not seem to be prospective. Compounds responsible for bioactivity were less polar in the analysed samples. The highest activity (78.54% inhibition on HeLa at 10 μg/mL) was observed in the case of the B extract of Paraleucobryum longifolium. Moreover, this extract was active on all the cell lines, and activities at 10 μg/mL were not much lower than those at 30 μg/mL (46.84–78.54% vs 56.87–83.93%). Interestingly, in the case of this species, only the CHCl3 extract had remarkable activities. Concerning the sensitivity of the cell lines, the measure of inhibition was more pronounced in the cases of HeLa and T47D than A2780. On HeLa, 16 extracts; on T47D, 10 extracts; and on A2780, only 3 extracts exerted >50% inhibition at 10 μg/mL. From the tested families, Brachytheciaceae (with Brachythecium rutabulum, Homalothecium philippeanum, and Pseudoscleropodium purum) and Amblystegiaceae (with Amblystegium serpens and Hygroamblystegium tenax) provided the highest numbers of active extracts.
The antimicrobial activity of the tested bryophytes, determined by the disc-diffusion method on 11 standard strains, seemed to be sporadic and of low intensity. From the 42 tested species, only 19 samples of 15 taxa showed moderate antibacterial activity (Table 2). None of the extracts were active on Pseudomonas aeruginosa ATCC 27853, Escherichia coli ATCC 35218, and Klebsiella pneumoniae ATCC 700603. Methicillin-resistant Staphylococcus aureus ATCC 43300 and Staphylococcus aureus ATCC 29213 proved to be the strains most susceptible to the examined species. Among the fractions with different polarities, the relatively apolar n-hexane and chloroform extracts demonstrated antibacterial activities. The aqueous and remnant MeOH fractions were inactive. From the tested species, Plagiomnium cuspidatum seemed to be the most prospective for further analysis of its antibacterial effects and constituents responsible for this activity, being active on eight tested strains.
There was a notable correlation between the antiproliferative and antimicrobial activities: 7 of the 14 species with antimicrobial activities and 7 of the 15 species with >50% inhibitory activity at 10 μg/mL on any of the cancer cell lines also possessed the other activity. Amblystegium serpens, Brachythecium rutabulum, Cirriphyllum piliferum, Climacium dendroides, Paraleucobryum longifolium, Plagiomnium affine, and Pseudoscleropodium purum were active in both assays.
For 14 species active in either of the assays, no chemical or pharmacological data are available in the literature (Amblystegium serpens (Hedw.) Schimp., Barbula unguiculata Hedw., Bryum caespiticium Hedw., Cirriphyllum piliferum (Hedw.) Grout, Dicranum tauricum Sapjegin, Encalypta streptocarpa Hedw., Hygroamblystegium tenax (Hedw.) Jenn., Neckera besseri (Lobarz.) Jur., Oxyrrhyncium hians (Hedw.) Loeske, Paraleucobryum longifolium (Hedw.) Loeske, Pseudoleskeella nervosa (Brid.) Nyholm, Schistidium crassipilum H. H. Blom, Syntrichia ruralis (Hedw.) F. Weber & D. Mohr, and Thuidium assimile (Mitt.) A. Jaeger) (Table 3). Ethnopharmacological data are scarce. Barbula unguiculata has been used as an analgesic and to reduce fever, and Bryum argenteum has been used as an antipyretic and as an antifungal agent in folk medicine [36]. The available data on biologically active species generally do not confirm or support our observations. In Anomodon viticulosus, previously only fatty acids were detected [37,38]; there are no data in literature on its antiproliferative and antimicrobial effects. In the case of Atrichum undulatum, the presence of the reported sterols [38], carotenoids [38], and fatty acids [39] may not be related to the antiproliferative activity; however, coumarin glycosides [40] may have some role in this effect. The DMSO (dimethyl sulfoxide) and aqueous extracts of this species were active against certain bacteria [41,42]; however the extracts analysed by us did not have such an effect. For Brachytheciastrum velutinum, only the presence of phenolic acids and flavonoids has been reported [43]. Brachythecium rutabulum possessed remarkable antibacterial activity [44], including against Staphylococcus aureus, as also demonstrated in our experiments. Bryum argenteum, with a confirmed flavonoid content [45,46], was reported to be active against different bacterial and fungal strains [8,47,48]. However, in our antimicrobial assay, it was not active. For Calliergonella cuspidata, only the presence of fatty acids [49] and antioxidant activity was reported [50], with no reference to the antimicrobial activity first observed by us. In the case of Climacium dendroides, both antiproliferative and antimicrobial effects have been reported [51]. From the secondary metabolites of this species, flavonoids and chromenones [51,52] might be related with these activities; however, the role of these compounds has not been investigated. Homalothecium philippeanum was antiproliferative in our assay but, contrary to previous results [53], exerted no antibacterial activity against Staphylococcus aureus. From Plagiomnium affine, which was active in both of our assays, only the presence of flavonoids has been reported previously [54]. Two other Plagiomnium species (P. cuspidatum and P. undulatum) had antimicrobial activities in our tests, with literature references only to their flavonoid contents [55,56,57,58]. In contrast to previous reports [53,59], Pleurozium schreberi did not exert antimicrobial activity. The sesquiterpene and flavonoid content of Porella platyphylla [60,61,62,63] may be related to its antiproliferative activity, but there are no reports on the anticancer effect of this species. From Pseudoscleropodium purum, only sterols, triterpenes, and essential oil have been reported [64,65,66]. The antimicrobial activity of Rhytidium rugosum was reported previously [53]. As part of our experiments, we carried out an LC-MS-based characterisation of the most biologically active extracts. Altogether, 58 compounds were identified from 9 different extracts (Table S4), the majority of which were acids and terpenoids. The limitation of this approach was that it allowed the identification of already known compounds. Further experiments will aim at the isolation and identification of bioactive constituents.

3. Discussion

The present investigation aimed at screening for antiproliferative and antimicrobial activities of selected bryophytes collected in Hungary. Our results and the lack of extensive scientific data on biologically active species suggest the necessity of further phytochemical and biological investigations. For the 14 species having antiproliferative or antimicrobial effects, this is the first report on their bioactivities.

4. Materials and Methods

4.1. Plant Material

Bryophytes were collected in the Northern Medium Mountains (Hungary) in September and October of 2014 and were identified by Péter Szűcs. Voucher specimens for each plant were deposited at the herbarium of the Institute of Pharmacognosy, University of Szeged. Extracts were prepared according to the method described previously [91]. Briefly, air-dried, powdered plant material was extracted using MeOH with the use of an ultrasonic bath. After filtration and evaporation, the residues were dissolved in 50% aqueous MeOH and subjected to solvent–solvent partition between n-hexane (extracts A) and CHCl3 (extracts B), and the remnant gave extracts C. The residual plant materials were dried and extracted with boiling H2O. The filtered extracts were freeze-dried, affording extracts D.

4.2. Antiproliferative Assay

The antiproliferative properties of the prepared extracts were determined by means of the MTT assay on a panel of human adherent cancerous cell lines of gynaecological origin containing A2780, HeLa, and T47D cells isolated from ovarian, cervical, and breast carcinomas, respectively. All the cells were purchased from ECACC (European Collection of Authenticated Cell Cultures, Salisbury, U.K.) and were cultivated in minimal essential medium supplemented with 10% fetal bovine serum, 1% non-essential amino acids, and an antibiotic–antimycotic mixture. All media and supplements were obtained from Lonza Group Ltd. (Basel, Switzerland). The cells were maintained at 37 °C in humidified atmosphere containing 5% CO2. Near-confluent cancer cells were seeded onto a 96-well microplate (5000 per well) and attached to the bottom of the well overnight. On the second day, 200 μL of new medium containing the tested substances (at 10 or 30 µg/mL) was added. After incubation for 72 h, the living cells were assayed by the addition of 20 μL of 5 mg/mL MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) solution. MTT was converted by intact mitochondrial reductase and precipitated as blue crystals during a 4 h contact period. The medium was then removed, and the precipitated crystals were dissolved in 100 μL of DMSO during a 60 min period of shaking at 25 °C. Finally, the reduced MTT was assayed at 545 nm using a microplate reader; wells with untreated cells were used as controls [92]. All experiments were carried out on two microplates with at least five parallel wells. Stock solutions of the tested substances (10 mg/mL) were prepared with DMSO. The highest DMSO content of the medium (0.3%) did not have any substantial effect on the cell proliferation. Cisplatin (Ebewe Pharma GmbH, Unterach, Austria), a clinically utilised anticancer drug, was used as a reference agent. The IC50 values of its antiproliferative action were 12.43, 1.30, and 9.78 μM against HeLa, A2780, and T47D cells, respectively.

4.3. Antimicrobial Assay

Antibacterial activities of the extracts against standard bacterial strains were screened for their inhibition zones by the standard disc-diffusion method described previously [93]. The test microorganisms used in this study were 11 international control standard strains. The standard Gram-positive strains were, namely, Bacillus subtilis (ATCC 6633), Staphylococcus aureus (ATCC 29213), Staphylococcus epidermidis (ATCC 12228), Streptococcus agalactiae (ATCC 13813), Streptococcus pneumoniae (ATCC 49619), Streptococcus pyogenes (ATCC 19615), and methicillin-resistant Staphylococcus aureus (ATCC 43300). The standard Gram-negative strains were, namely, Escherichia coli (ATCC 35218), Klebsiella pneumoniae (ATCC 700603), and Moraxella catarrhalis (ATCC 43617). Microbial cultures were grown on standard Mueller-Hinton agar plates or Columbia agar +5% sheep blood (COS) plates (bioMérieux, Marcy-l’Étoile, France) at 37 °C under an aerobic or 5% CO2 environment. The strains were stored in Cryobank vials (MAST Diagnostica, Rheinfeld, Germany) at −70 °C and maintained at 4 °C throughout the study to use as stock cultures. Briefly, bryophyte extracts were dissolved in DMSO (Sigma-Aldrich, St. Louis, MO, USA) or water at a concentration of 50 mg mL−1. The sterile filter paper discs (6 mm in diameter) impregnated with the extracts (10 uL of redissolved extracts) were placed on the plate seeded with the respective bacterial suspensions (inoculums: 0.5 McFarland, 1–2 × 108 CFU mL−1). The solvent (DMSO) served as the negative control, while ampicillin, erythromycin, imipenem, cefuroxime, and vancomycin antibiotic susceptibility discs were used as the positive control. The plates were incubated at 37 °C for 24 h under aerobic or 5% CO2 conditions. The diameters of inhibition zones produced by the extracts (including the disc) were measured and recorded. All experiments were carried out in triplicate.

4.4. Phytochemical Characterisation of the Extracts

The most active samples were analysed phytochemically by LC-MS. Samples were filtered through 0.45 µm PTFE (polytetrafluoroethylene) syringe filters before analysis. For separation, Kinetex (Phenomenex; XB-C18 and Phenyl-Hexyl, 2.1 × 100 mm, 2.6 um, 100 Å) columns were used. The eluents were the following: A: 0.1% formic acid in MS-grade water; B: 0.1% formic acid in MS-grade acetonitrile. The separation was done with a linear gradient from 5% to 95% B in 35 min with a 0.3 mL/min flow rate. The HPLC instrument was an Agilent 1100 series model consisting of a binary pump, a thermostated autosampler, and a column compartment. The mass spectrometer was a Thermo Q-Exactive Plus Orbitrap equipped with a HESI-II ion source. The mass accuracy was 0.25+/−0.01 ppm in the positive mode and 0.34+/−0.05 in the negative mode at the mass calibration just before the experiment. Acquisition was done in the data-dependent MS2 scan mode by altering the charge state (positive/negative). The survey scan mass range was set to m/z 80–1000, using the lock masses from the known background ions listed in Table S2. The data-dependent method parameters are shown in Table S3. The acquired MS2 peak lists were converted to a text file by using the msConvert tool (Proteowizard), and the top 100 MS survey scan peaks were chosen for MS2 identification against KEGG’s small-molecule database, using the MetFrag online search tool. The hits were filtered manually using an 80% matched peak result when the number of MS2 fragment peaks was at least five.

Supplementary Materials

The following are available online: Table S1: Antiproliferative activities against cancer cell lines treated with extracts A–D for an exposure time of 72 h (mean ± SEM); Table S2: The used lock masses and the charge state mode; Table S3: Parameters of the data-dependent acquisition in both charge states; Table S4: Compounds identified by LC-MS.

Author Contributions

Conceptualisation: D.C., M.M., I.Z., and E.U.; methodology: A.G. and P.S.; investigation: B.C.-L., P.B., E.L.-B., M.V., A.V., and A.C.; data curation: D.C. and I.Z.; writing—original draft preparation: D.C.; writing—review and editing: I.Z. and M.M.; supervision: D.C.

Funding

This research was funded by the National Research, Development and Innovation Office (OTKA K115796); the Economic Development and Innovation Operative Programme GINOP-2.3.2-15-2016-00012; and the János Bolyai Research Scholarship of the Hungarian Academy of Sciences.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 2012, 75, 311–335. [Google Scholar] [CrossRef] [PubMed]
  2. Stewart, B.W.; Wild, C.P. World Cancer Report; WHO: Geneva, Switzerland, 2014. [Google Scholar]
  3. Paul, G.G.; Gordon, M.C.; David, J.N. Plant Natural Products in Anticancer Drug Discovery. Curr. Org. Chem. 2010, 14, 1781–1791. [Google Scholar] [CrossRef]
  4. Asakawa, Y. Liverworts-Potential Source of Medicinal Compounds. Med. Aromat. Plants 2012, 1. [Google Scholar] [CrossRef]
  5. Shaw, A.J. (Ed.) Bryophyte Biology; Cambridge University Press: Cambridge, UK, 2009; ISBN 9780521693226. [Google Scholar]
  6. Papp, B.; Erzberger, P.; Ódor, P.; Hock, Z.; Szövényi, P.; Szurdoki, E.; Tóth, Z. Updated Checklist And Red List of Hungarian Bryophytes—2010 Regional Red List. Stud. Bot. Hung. 2010, 41, 31–59. [Google Scholar]
  7. Asakawa, Y.; Ludwiczuk, A.; Nagashima, F. Phytochemical and biological studies of bryophytes. Phytochemistry 2013, 91, 52–80. [Google Scholar] [CrossRef] [PubMed]
  8. McCleary, J.A.; Sypherd, P.S.; Walkington, D.L. Mosses as Possible Sources of Antibiotics. Science 1960, 131, 108. [Google Scholar] [CrossRef] [PubMed]
  9. McCleary, J.A.; Walkington, D.L. Mosses and Antibiosis. Rev. Bryol. Lichenol. 1966, 34, 309–314. [Google Scholar]
  10. Banerjee, R.D.; Sen, S.P. Antibiotic Activity of Bryophytes. Bryologist 1979, 82, 141–153. [Google Scholar] [CrossRef]
  11. Kim, S.-J.; Park, H.-R.; Park, E.; Lee, S.-C. Cytotoxic and Antitumor Activity of Momilactone B from Rice Hulls. J. Agric. Food Chem. 2007, 55, 1702–1706. [Google Scholar] [CrossRef] [PubMed]
  12. Baek, S.-H.; Phipps, R.K.; Perry, N.B. Antimicrobial Chlorinated Bibenzyls from the Liverwort Riccardiamarginata. J. Nat. Prod. 2004, 67, 718–720. [Google Scholar] [CrossRef] [PubMed]
  13. Figueiredo, A.C.; Sim-Sim, M.; Barroso, J.G.; Pedro, L.G.; Santos, P.A.G.; Fontinha, S.S.; Schripsema, J.; Deans, S.G.; Scheffer, J.J.C. Composition of the Essential Oil From the Liverwort Marchesinia mackaii (Hook.) S. F. Gray Grown in Portugal. J. Essent. Oil Res. 2002, 14, 439–442. [Google Scholar] [CrossRef]
  14. Asakawa, Y.; Ludwiczuk, A.; Nagashima, F.; Toyota, M.; Hashimoto, T.; Tori, M.; Fukuyama, Y.; Harinantenaina, L. Bryophytes: Bio- and Chemical Diversity, Bioactivity and Chemosystematics. Heterocycles 2009, 77, 99–150. [Google Scholar] [CrossRef]
  15. Shu, Y.-F.; Wei, H.-C.; Wu, C.-L. Sesquiterpenoids from liverworts Lepidozia vitrea and L. Fauriana. Phytochemistry 1994, 37, 773–776. [Google Scholar] [CrossRef]
  16. Asakawa, Y. Biologically active substances from bryophytes. In Bryophyte Development: Physiology and Biochemistry; Chopra, R.N., Bhatla, S.C., Eds.; CRC Press: Boca Raton, FL, USA, 1990; pp. 259–287. [Google Scholar]
  17. Scher, J.M.; Burgess, E.J.; Lorimer, S.D.; Perry, N.B. A cytotoxic sesquiterpene and unprecedented sesquiterpene-bisbibenzyl compounds from the liverwort Schistochila glaucescens. Tetrahedron 2002, 58, 7875–7882. [Google Scholar] [CrossRef]
  18. Harinantenaina, L.; Asakawa, Y. Chemical constituents of Malagasy liverworts, part II: Mastigophoric acid methyl ester of biogenetic interest from Mastigophora diclados (Lepicoleaceae Subf. Mastigophoroideae). Chem. Pharm. Bull. 2004, 52, 1382–1384. [Google Scholar] [CrossRef] [PubMed]
  19. Komala, I.; Ito, T.; Nagashima, F.; Yagi, Y.; Asakawa, Y. Cytotoxic, radical scavenging and antimicrobial activities of sesquiterpenoids from the Tahitian liverwort Mastigophora diclados (Brid.) Nees (Mastigophoraceae). J. Nat. Med. 2010, 64, 417–422. [Google Scholar] [CrossRef] [PubMed]
  20. Scher, J.M.; Schinkovitz, A.; Zapp, J.; Wang, Y.; Franzblau, S.G.; Becker, H.; Lankin, D.C.; Pauli, G.F. Structure and Anti-TB Activity of Trachylobanes from the Liverwort Jungermannia exsertifolia ssp. cordifolia. J. Nat. Prod. 2010, 73, 656–663. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  21. Dey, A.; Mukherjee, A. Therapeutic potential of bryophytes and derived compounds against cancer. J. Acute Dis. 2015, 4, 236–248. [Google Scholar] [CrossRef]
  22. Toyota, M.; Tanimura, K.; Asakawa, Y. Cytotoxic 2,3-Secoaromadendrane-Type Sesquiterpenoids from the Liverwort Plagiochila ovalifolia. Planta Med. 1998, 64, 462–464. [Google Scholar] [CrossRef] [PubMed]
  23. Kim, Y.; da S Bolzani, V.; Baj, N.; Gunatilaka, A.; Kingston, D. A DNA-Damaging Sesquiterpene and Other Constituents from Frullania nisquallensis. Planta Med. 1996, 62, 61–63. [Google Scholar] [CrossRef] [PubMed]
  24. Stephen, D.L.; Nigel, B.P.; Elaine, J.B.; Foster, L.M. 1-Hydroxyditerpenes from Two New Zealand Liverworts, Paraschistochila pinnatifolia and Trichocolea mollissima. J. Nat. Prod. 1997, 60, 421–424. [Google Scholar] [CrossRef]
  25. Perry, N.B.; Burgess, E.J.; Tangney, R.S. Cytotoxic 8,9-secokaurane diterpenes from a New Zealand liverwort, Lepidolaena taylorii. Tetrahedron Lett. 1996, 37, 9387–9390. [Google Scholar] [CrossRef]
  26. Neves, M.; Morais, R.; Gafner, S.; Hostettmann, K. Three triterpenoids and one flavonoid from the liverwort Asterella blumeana grown in vitro. Phyther. Res. 1998, 12, S21–S24. [Google Scholar] [CrossRef]
  27. Huang, W.-J.; Wu, C.-L.; Lin, C.-W.; Chi, L.-L.; Chen, P.-Y.; Chiu, C.-J.; Huang, C.-Y.; Chen, C.-N. Marchantin A, a cyclic bis(bibenzyl ether), isolated from the liverwort Marchantia emarginata subsp. tosana induces apoptosis in human MCF-7 breast cancer cells. Cancer Lett. 2010, 291, 108–119. [Google Scholar] [CrossRef] [PubMed]
  28. Nagashima, F.; Kasai, W.; Kondoh, M.; Fujii, M.; Watanabe, Y.; Braggins, J.E.; Asakawa, Y. New ent-kaurene-type diterpenoids possessing cytotoxicity from the New Zealand liverwort Jungermannia species. Chem. Pharm. Bull. 2003, 51, 1189–1192. [Google Scholar] [CrossRef] [PubMed]
  29. Xi, G.; Sun, B.; Jiang, H.; Kong, F.; Yuan, H.; Lou, H. Bisbibenzyl derivatives sensitize vincristine-resistant KB/VCR cells to chemotherapeutic agents by retarding P-gp activity. Bioorg. Med. Chem. 2010, 18, 6725–6733. [Google Scholar] [CrossRef] [PubMed]
  30. Shi, Y.-Q.; Liao, Y.-X.; Qu, X.-J.; Yuan, H.-Q.; Li, S.; Qu, J.-B.; Lou, H.-X. Marchantin C, a macrocyclic bisbibenzyl, induces apoptosis of human glioma A172 cells. Cancer Lett. 2008, 262, 173–182. [Google Scholar] [CrossRef] [PubMed]
  31. Shi, Y.; Qu, X.; Liao, Y.; Xie, C.; Cheng, Y.; Li, S.; Lou, H. Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562/A02 cells. Eur. J. Pharmacol. 2008, 584, 66–71. [Google Scholar] [CrossRef] [PubMed]
  32. Nagashima, F.; Kondoh, M.; Uematsu, T.; Nishiyama, A.; Saito, S.; Sato, M.; Asakawa, Y. Cytotoxic and apoptosis-inducing ent-kaurane-type diterpenoids from the Japanese liverwort Jungermannia truncata NEES. Chem. Pharm. Bull. 2002, 50, 808–813. [Google Scholar] [CrossRef] [PubMed]
  33. Nagashima, F.; Kondoh, M.; Kawase, M.; Simizu, S.; Osada, H.; Fujii, M.; Watanabe, Y.; Sato, M.; Asakawa, Y. Apoptosis-Inducing Properties of ent-Kaurene-Type Diterpenoids from the Liverwort Jungermannia truncata. Planta Med. 2003, 69, 377–379. [Google Scholar] [CrossRef] [PubMed]
  34. Kondoh, M.; Nagashima, F.; Suzuki, I.; Harada, M.; Fujii, M.; Asakawa, Y.; Watanabe, Y. Induction of Apoptosis by New ent-Kaurene-Type Diterpenoids Isolated from the New Zealand Liverwort Jungermannia Species. Planta Med. 2005, 71, 1005–1009. [Google Scholar] [CrossRef] [PubMed]
  35. Shi, Y.; Zhu, C.; Yuan, H.; Li, B.; Gao, J.; Qu, X.; Sun, B.; Cheng, Y.; Li, S.; Li, X.; et al. Marchantin C, a novel microtubule inhibitor from liverwort with anti-tumor activity both in vivo and in vitro. Cancer Lett. 2009, 276, 160–170. [Google Scholar] [CrossRef] [PubMed]
  36. Chandra, S.; Chandra, D.; Barh, A.; Pankaj; Pandey, R.K.; Sharma, I.P. Bryophytes: Hoard of remedies, an ethno-medicinal review. J. Tradit. Complement. Med. 2016. [Google Scholar] [CrossRef] [PubMed]
  37. Catalano, S.; Marsili, A.; Morelli, I.; Pacchiani, M. Triterpenoids and fatty acids from some mosses. obtusifoliol from Racomitrium lanuginosum. Phytochemistry 1976. [Google Scholar] [CrossRef]
  38. Dembitsky, V.M. Lipids of bryophytes. Prog. Lipid Res. 1993, 32, 281–356. [Google Scholar] [CrossRef]
  39. Pejin, B.; Vujisic, L.; Sabovljevic, M.; Tesevic, V.; Vajs, V. Fatty acid chemistry of Atrichum undulatum and Hypnum andoi. Hem. Ind. 2012, 66, 207–209. [Google Scholar] [CrossRef]
  40. Jung, M.; Zinsmeister, H.D.; Geiger, H. New 3-Oxygenated and Tetraoxygenated Coumarin Glucosides from the Mosses Atrichum-Undulatum and Polytrichum-Formosum. Z. Naturforsch. C 1994, 49, 153. [Google Scholar]
  41. Sabovljevic, A.; Sokovic, M.; Glamoclija, J.; Ciric, A.; Vujicic, M.; Pejin, B.; Sabovljevic, M. Comparison of extract bio-activities of in-situ and in vitro grown selected bryophyte species. Afr. J. Microbiol. Res. 2010, 4, 808–812. [Google Scholar]
  42. Nikolajeva, V.; Liepina, L.; Petrina, Z.; Krumina, G.; Grube, M.; Muiznieks, I. Antibacterial activity of extracts from some Bryophytes. Adv. Microbiol. 2012, 2, 345–353. [Google Scholar] [CrossRef]
  43. Jockovic, N.; Andrade, P.B.; Valentao, P.; Sabovljevic, M. HPLC-DAD of phenolics in bryophytes Lunularia cruciata, Brachytheciastrum velutinum and Kindbergia praelonga. J. Serbian Chem. Soc. 2008, 73, 1161–1167. [Google Scholar] [CrossRef]
  44. Singh, M.; Rawat, A.K.S.; Govindarajan, R. Antimicrobial activity of some Indian mosses. Fitoterapia 2007, 78, 156–158. [Google Scholar] [CrossRef] [PubMed]
  45. Markham, K.R.; Given, D.R. The major flavonoids of an antarctic Bryum. Phytochemistry 1988, 27, 2843–2845. [Google Scholar] [CrossRef]
  46. Ryan, K.G.; Burne, A.; Seppelt, R.D. Historical ozone concentrations and flavonoid levels in herbarium specimens of the Antarctic moss Bryum argenteum. Glob. Chang. Biol. 2009. [Google Scholar] [CrossRef]
  47. Singh, M.; Singh, S.; Nath, V.; Sahu, V.; Rawat, A.K.S. Antibacterial activity of some bryophytes used traditionally for the treatment of burn infections. Pharm. Biol. 2011, 49, 526–530. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  48. Sabovljevic, A.; Sokovic, M.; Sabovljevic, M.; Grubisic, D. Antimicrobial activity of Bryum argenteum. Fitoterapia 2006, 77, 144–145. [Google Scholar] [CrossRef] [PubMed]
  49. Pejin, B.; Vujisic, L.; Sabovljevic, M.; Tesevic, V.; Vajs, V. An Insight into Fatty Acid Composition of Calliergonella cuspidata. Asian J. Chem. 2011, 23, 5161–5162. [Google Scholar]
  50. Pejin, B.; Bogdanovic-Pristov, J. ABTS Cation scavenging activity and total phenolic content of three moss species. Hem. Ind. 2012, 66, 723–726. [Google Scholar] [CrossRef]
  51. Klavina, L.; Springe, G.; Nikolajeva, V.; Martsinkevich, I.; Nakurte, I.; Dzabijeva, D.; Steinberga, I. Chemical composition analysis, antimicrobial activity and cytotoxicity screening of moss extracts (moss phytochemistry). Molecules 2015, 20, 17221–17243. [Google Scholar] [CrossRef] [PubMed]
  52. Nam, J.H.; Cho, I.S.; Kim, S.J.; Nam, C.W.; Seo, J.T.; Yoo, D.L.; Kim, W.B.; Ryu, S.Y.; Lee, E.H.; Kim, M.Y.; et al. Phytochemical constituents of Climacium dendroides. J. Korean Soc. Appl. Biol. Chem. 2008, 51, 136–141. [Google Scholar]
  53. Veljic, M.; Tarbuk, M.; Martin, P.D.; Ciric, A.; Sokovic, M.; Marin, M. Antimicrobial Activity of Methanol Extracts of Mosses from Serbia. Pharm. Biol. 2008, 46, 871–875. [Google Scholar] [CrossRef]
  54. Freitag, P.; Mues, R.; Brill-Fess, C.; Stoll, M.; Zinsmeister, H.D.; Markham, K.R. Isoorientin 3′-O-sophoroside and 3′-O-neohesperidoside from the moss Plagiomnium affine. Phytochemistry 1986, 25, 669–671. [Google Scholar] [CrossRef]
  55. Basile, A.; Sorbo, S.; Lopez-Saez, J.A.; Castaldo Cobianchi, R.; López-Sáez, J.A.; Castaldo Cobianchi, R. Effects of seven pure flavonoids from mosses on germination and growth of Tortula muralis HEDW. (Bryophyta) and Raphanus sativus L. (Magnoliophyta). Phytochemistry 2003, 62, 1145–1151. [Google Scholar] [CrossRef]
  56. Anhut, S.; Biehl, J.; Seeger, T.; Mues, R.; Zinsmeister, H.D. Flavone-C-Glycosides from the Mosses Plagiomnium-Elatum and Plagiomnium-Cuspidatum. Z. Naturforsch. C 1992, 47, 654–660. [Google Scholar]
  57. Rampendahl, C.; Seeger, T.; Geiger, H.; Zinsmeister, H.D. The biflavonoids of Plagiomnium undulatum. Phytochemistry 1996, 41, 1621–1624. [Google Scholar] [CrossRef]
  58. Österdahl, B.-G. Chemical Studies on Bryophytes. 22. Flavonoid C-Glycosides of Mnium undulatum. Acta Chem. Scand. 1979, 33, 400–404. [Google Scholar] [CrossRef]
  59. Kang, S.J.; Kim, S.H.; Liu, P.; Jovel, E.; Towers, G.H.N. Antibacterial activities of some mosses including Hylocomium splendens from South Western British Columbia. Fitoterapia 2007, 78, 373–376. [Google Scholar] [CrossRef] [PubMed]
  60. Asakawa, Y.; Toyota, M.; Takemoto, T.; Suire, C. Pinguisanin, pinguisanolide and β-pinguisenediol, three new pinguisane-type sesquiterpenes from Porella platyphylla. Phytochemistry 1979, 18, 1349–1353. [Google Scholar] [CrossRef]
  61. Buchanan, M.S.; Connolly, J.D.; Rycroft, D.S. Pinguisane and sacculatane terpenoids from the liverwort Porella platyphylla. Phytochemistry 1996, 43, 1249–1253. [Google Scholar] [CrossRef]
  62. Nilsson, E. Apigenin-6,8-di-C-glycoside from Porella platyphylla. Phytochemistry 1973, 12, 722–723. [Google Scholar] [CrossRef]
  63. Mues, R. Occurrence and absence of C-glycosylflavones in species of the liverwort genera Blepharostoma, Herbertus, Mastigophora, Porella, Ptilidium, and Trichocolea: An indication of taxonomic significance? J. Hattori Bot. Lab. 1982, 53, 271–281. [Google Scholar]
  64. Chiu, P.-L.; Patterson, G.W.; Fenner, G.P. Sterols of bryophytes. Phytochemistry 1985, 24, 263–266. [Google Scholar] [CrossRef]
  65. Marsili, A.; Morelli, I.; Iori, A.M. 21-Hopene and some other constituents of Pseudoscleropodium purum. Phytochemistry 1971. [Google Scholar] [CrossRef]
  66. Tosun, G.; Yayli, B.; Ozdemir, T.; Batan, N.; Bozdeveci, A.; Yayli, N.; Gonca, G.; Yayli, B.; Ozdemir, T.; Batan, N.; et al. Volatiles and Antimicrobial Activity of the Essential Oils of the Mosses Pseudoscleropodium purum, Eurhynchium striatum, and Eurhynchium angustirete Grown in Turkey. Rec. Nat. Prod. 2015, 9, 237–242. [Google Scholar]
  67. Marsili, A.; Morelli, I.; Bernardini, C.; Pacchiani, M. Constituents of some mosses. Phytochemistry 1972, 11, 2003–2005. [Google Scholar] [CrossRef]
  68. Huneck, S. Die inhaltsstoffe der laubmoose Abietinella abietina, Plagiothecium undulatum und Tortella inclinata. Phytochemistry 1971, 10, 3262–3283. [Google Scholar] [CrossRef]
  69. Bukvicki, D.; Veljic, M.; Sokovic, M.; Grujic, S.; Marin, P.D. Antimicrobial Activity of Methanol Extracts of Abietinella abietina, Neckera crispa, Platyhypnidium riparoides, Cratoneuron filicinum and Campylium protensum Mosses. Arch. Biol. Sci. 2012, 64, 911–916. [Google Scholar] [CrossRef]
  70. Chobot, V.; Kubicova, L.; Nabbout, S.; Jahodar, L.; Hadacek, F. Evaluation of antioxidant activity of some common mosses. Z. Naturforsch. C 2008, 63, 476–482. [Google Scholar] [CrossRef] [PubMed]
  71. Croisier, E.; Rempt, M.; Pohnert, G. Survey of volatile oxylipins and their biosynthetic precursors in bryophytes. Phytochemistry 2010, 71, 574–580. [Google Scholar] [CrossRef] [PubMed]
  72. Pejin, B.; Vujisic, L.; Sabovljevic, A.; Sabovljevic, M.; Tesevic, V.; Vajs, V. Fatty acids of some moss species from Germany. Asian J. Chem. 2011, 23, 5187–5188. [Google Scholar]
  73. Pejin, B.; Bogdanovic-Pristov, J.; Pejin, I.; Sabovljevic, M. Potential antioxidant activity of the moss Bryum moravicum. Nat. Prod. Res. 2013, 27, 900–902. [Google Scholar] [CrossRef] [PubMed]
  74. Vandekerkhove, O. The occurrence of flavonoids in the acrocarpous mosses. II. Luteolin from the sporophyte of Ceratodon purpureus (L.) Brid. Z. Pflanzenphysiol. 1978, 86, 279–281. [Google Scholar] [CrossRef]
  75. Minto, R.E.; Blacklock, B.J. Biosynthesis and function of polyacetylenes and allied natural products. Prog. Lipid Res. 2008, 47, 233–306. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  76. Wang, X.-N.; Bashyal, B.P.; Wijeratne, E.M.K.; U’Ren, J.M.; Liu, M.X.; Gunatilaka, M.K.; Arnold, A.E.; Gunatilaka, A.A.L. Smardaesidins A-G, isopimarane and 20-nor-isopimarane diterpenoids from Smardaea sp., a fungal endophyte of the moss Ceratodon purpureus. J. Nat. Prod. 2011, 74, 2052–2061. [Google Scholar] [CrossRef] [PubMed]
  77. Chobot, V.; Kubicova, L.; Nabbout, S.; Jahodar, L.; Vytlacilova, J. Antioxidant and free radical scavenging activities of five moss species. Fitoterapia 2006, 77, 598–600. [Google Scholar] [CrossRef] [PubMed]
  78. Weitz, S.; Ikan, R. Bracteatin from the moss Funaria hygrometrica. Phytochemistry 1977, 16, 1108–1109. [Google Scholar] [CrossRef]
  79. Savaroglu, F.; Ilhan, S.; Filik-Iscen, C. An evaluation of the antimicrobial activity of some Turkish mosses. J. Med. Plants Res. 2011, 5, 3286–3292. [Google Scholar]
  80. Seeger, T.; Geiger, H.; Zinsmeister, H.D.; Rozdzinski, W. Biflavonoids from the Moss Homalothecium lutescens. Phytochemistry 1993, 34, 295–296. [Google Scholar] [CrossRef]
  81. Ucuncu, O.; Cansu, T.B.; Ozdemir, T.; Karaoglu, S.A.; Yayli, N. Chemical composition and antimicrobial activity of the essential oils of mosses (Tortula muralis Hedw., Homalothecium lutescens (Hedw.) H. Rob., Hypnum cupressiforme Hedw., and Pohlia nutans (Hedw.) Lindb.) from Turkey. Turk. J. Chem. 2010, 34, 825–834. [Google Scholar] [CrossRef]
  82. Cansu, T.B.; Yayli, B.; Ozdemir, T.; Batan, N.; Alpay Karaoglu, S.; Yayli, N. Antimicrobial activity and chemical composition of the essential oils of mosses (Hylocomium splendens (Hedw.) Schimp. and Leucodon sciuroides (Hedw.) Schwagr.) growing in Turkey. Turk. J. Chem. 2013, 37, 213–219. [Google Scholar] [CrossRef]
  83. Dulger, B.; Yayintas, O.T.; Gonuz, A. Antimicrobial activity of some mosses from Turkey. Fitoterapia 2005, 76, 730–732. [Google Scholar] [CrossRef] [PubMed]
  84. Özdemır, T.; Yaylı, N.; Cansu, T.B.; Volga, C. Essential oils in mosses (Brachythecium salebrosum, Eurhynchium pulchellum and Plagiomnium undulatum) grown in Turkey. Asian J. Chem. 2009, 21, 5505–5509. [Google Scholar]
  85. Vandekerkhove, O. Über die Verbreitung von Flavonoiden bei pleurokarpen Laubmoosen II. Apigenin and Apigenin-7-rhamnoglucosid bei Pleurozium schreberi (Willd.) Mitt. Z. Pflanzenphysiol. 1980, 100, 369–372. [Google Scholar] [CrossRef]
  86. Abay, G.; Altun, M.; Karakoc, O.C.; Gul, F.; Demirtas, I. Insecticidal Activity of Fatty Acid-Rich Turkish Bryophyte Extracts against Sitophilus granarius (Coleoptera: Curculionidae). Comb. Chem. High Throughput Screen. 2013, 16, 806–816. [Google Scholar] [CrossRef] [PubMed]
  87. Nagashima, F.; Momosaki, S.; Watanabe, Y.; Toyota, M.; Huneck, S.; Asakawa, Y. Terpenoids and aromatic compounds from six liverworts. Phytochemistry 1996, 41, 207–211. [Google Scholar] [CrossRef]
  88. Tosun, A.; Akkol, E.K.; Suntar, I.; Kiremit, H.O.; Asakawa, Y. Phytochemical investigations and bioactivity evaluation of liverworts as a function of anti-inflammatory and antinociceptive properties in animal models. Pharm. Biol. 2013, 51, 1008–1013. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  89. Seeger, T.; Zinsmeister, H.D.; Geiger, H. The biflavonoid pattern of Rhytidiadelphus squarrosus (Hedw.) Warnst. Z. Naturforsch. C 1990, 45, 583–586. [Google Scholar]
  90. Li, L.; Wu, J.; Han, T.; Qin, L. Chemical composition of the essential oil and ether extract from Rhytidium rugosum. Chem. Nat. Compd. 2008, 44, 797–799. [Google Scholar] [CrossRef]
  91. Réthy, B.; Csupor-Löffler, B.; Zupkó, I.; Hajdú, Z.; Máthé, I.; Hohmann, J.; Rédei, T.; Falkay, G. Antiproliferative activity of Hungarian Asteraceae species against human cancer cell lines. Part I. Phyther. Res. 2007, 21, 1200–1208. [Google Scholar] [CrossRef] [PubMed]
  92. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55–63. [Google Scholar] [CrossRef]
  93. Bauer, A.W.; Kirby, W.M.; Sherris, J.C.; Turck, M. Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol. 1966, 45, 493–496. [Google Scholar] [CrossRef] [PubMed]
Sample Availability: Samples of the extracts are available from the authors.
Table
Table 1. Antiproliferative activities against cancer cell lines treated with extracts for an exposure time of 72 h; values exceeding 50% inhibition are coloured from yellow to green; extracts exerting less than 25% inhibition of cancer cell growth were considered inactive (red), and their exact results are not given numerically; SEM (standard error of the mean) values reported in Table S1.
Table 1. Antiproliferative activities against cancer cell lines treated with extracts for an exposure time of 72 h; values exceeding 50% inhibition are coloured from yellow to green; extracts exerting less than 25% inhibition of cancer cell growth were considered inactive (red), and their exact results are not given numerically; SEM (standard error of the mean) values reported in Table S1.
SpeciesExtract AExtract B
HeLaA2780T47DHeLaA2780T47D
10 µg/mL30 µg/mL10 µg/mL30 µg/mL10 µg/mL30 µg/mL10 µg/mL30 µg/mL10 µg/mL30 µg/mL10 µg/mL30 µg/mL
Abietinella abietina<25<25<25<25<2532.2630.0038.62<25<2542.9948.97
Amblystegium serpens<2546.1329.5849.9449.1570.1561.9370.7853.4665.3570.1574.76
Anomodon viticulosus26.9650.72<25<25<2527.8127.0449.3532.3553.87<2536.32
Atrichum undulatum<25<25<25<25<2541.6659.9376.2637.7864.2864.1165.26
Barbula unguiculata45.7463.27<25<25<2534.1465.4675.11<2547.4744.2053.16
Brachytheciastrum velutinum31.9264.96<2535.58<2541.0134.4355.09<2561.2934.4351.51
Brachythecium rutabulum53.4961.6425.0434.9345.4055.3651.9553.89<2535.3046.7954.92
Bryum argenteum47.7980.09<25<25<25<2536.1154.52<25<2535.9541.26
Bryum caespiticium30.3757.84<25<25<2548.8048.6459.57<25<2528.5848.17
Bryum moravicum<2538.27<25<25<2529.7346.7262.0927.3448.2240.6459.69
Calliergonella cuspidata<25<25<25<25<25<25<2532.79<25<2539.0249.49
Ceratodon purpureus<2526.67<2532.49<2528.8830.6742.00<2535.18<2528.48
Cirriphyllum piliferum51.3467.39<2542.24<2531.19<2528.32<25<25<25<25
Climacium dendroides52.7963.79<2532.63<25<2556.7964.89<25<2555.4657.16
Dicranum tauricum<25<25<2528.55<2531.6033.1451.60<2548.9435.3854.93
Encalypta streptocarpa76.6661.3234.0487.9025.7244.0854.4672.9073.7280.1233.2233.27
Funaria hygrometrica<2539.84<25<25<2536.2148.4462.8825.6651.0646.4453.18
Homalothecium lutescens<2537.79<2531.59<2530.29<25<25<25<2528.7430.64
Homalothecium philippeanum38.3463.66<2540.7737.3948.1946.9373.7733.6074.9363.9062.51
Hygroamblystegium tenax<2551.08<2526.5328.3443.7536.9943.86<25<2549.1955.28
Leskea polycarpa<2529.00<2537.18<2525.71<2531.32<2535.02<2537.07
Leucodon sciuroides26.0043.88<25<25<2534.4342.4861.74<25<2528.8839.63
Neckera besseri54.2968.98<25<2533.7238.3369.1383.28<2576.4850.0768.26
Orthotrichum diaphanum<2528.22<25<25<25<2540.1951.7525.0450.6535.4340.61
Oxyrrhynchium hians<2550.41<2542.2226.0346.4625.6539.79<2528.6134.0146.64
Paraleucobryum longifolium<2527.34<25<25<25<2578.5483.9363.2378.0346.8456.87
Plagiomnium affine<2541.79<25<25<25<2542.4155.53<2542.1142.4956.05
Plagiomnium cuspidatum39.1339.4426.4997.60<2586.33<25<25<2556.15<2536.11
Plagiomnium rostratum26.0160.72<2544.9928.6836.2646.5260.2243.2367.0645.5654.59
Plagiomnium undulatum35.7733.42<2526.0729.3643.49<25<25<2533.21<2532.10
Pleurozium schreberi61.8593.4141.1537.25<2531.6560.4974.30<2536.8929.2643.95
Pohlia nutans<25<25<25<25<25<2529.5149.60<25<25<25<25
Polytrichastrum formosum<2534.69<25<25<2528.85<2534.18<25<25<25<25
Porella platyphylla31.8979.2248.2283.3348.9464.3735.6947.36<2541.9329.3347.86
Pseudoleskeella nervosa68.4375.64<25<2538.9443.6961.7171.88<2536.2842.7745.50
Pseudoscleropodium purum<2534.16<25<25<25<2562.0670.27<2528.0153.8854.58
Rhytidiadelphus squarrosus<25<25<25<25<25<2543.9953.66<25<2540.3151.65
Rhytidium rugosum32.3456.50<2536.29<2525.8030.2039.48<25<25<2527.52
Schistidium crassipilum<2533.32<25<25<25<2527.5253.09<2572.36<2538.36
Syntrichia ruralis<25<25<25<25<25<2527.0533.02<25<2530.4939.25
Thamnobryum alopecurum29.9857.12<2526.75<25<2534.3553.87<2551.91<25<25
Thuidium assimile<25<25<2529.18<25<2543.3657.0934.6258.8665.7056.12
SpeciesExtract CExtract D
HeLaA2780T47DHeLaA2780T47D
10 µg/mL30 µg/mL10 µg/mL30 µg/mL10 µg/mL30 µg/mL10 µg/mL30 µg/mL10 µg/mL30 µg/mL10 µg/mL30 µg/mL
Abietinella abietina35.2552.48<25<2538.2249.01<25<25<25<25<2530.04
Amblystegium serpens33.1944.83<2526.7148.5858.34<25<25<25<2527.9135.73
Anomodon viticulosus<2534.02<25<25<2527.47<25<25<25<25<25<25
Atrichum undulatum29.1441.65<2546.14<2537.9533.3736.14<25<25<25<25
Barbula unguiculata29.6835.91<25<25<2527.6827.9227.4<25<25<25<25
Brachytheciastrum velutinum<2532.09<25<2527.2634.734.934.68<25<2538.5338.46
Brachythecium rutabulum<2534.26<25<25<2534.81<25<25<25<25<25<25
Bryum argenteum<25<25<25<25<25<25<25<25<25<25<25<25
Bryum caespiticium<2535.57<25<25<25<25<25<25<25<25<25<25
Bryum moravicum<2537.94<25<25<2526.51<25<25<25<25<25<25
Calliergonella cuspidata<25<25<25<25<25<25<25<25<25<25<25<25
Ceratodon purpureus<25<25<25<25<2531.86<25<25<25<25<25<25
Cirriphyllum piliferum28.1842.07<25<25<2526.85<2532.27<25<25<25<25
Climacium dendroides<25<25<25<25<2527.68<2527.42<25<2527.3837.52
Dicranum tauricum<2528.29<25<2533.5249.9729.7537.11<25<2545.3147.21
Encalypta streptocarpa28.0139.61<25<25<2532.527.05<25<25<25<25<25
Funaria hygrometrica<25<25<25<2542.2748.2225.1138.47<25<2535.445.16
Homalothecium lutescens<25<25<25<25<25<25<25<25<25<25<2527.6
Homalothecium philippeanum<2533.51<2528.0443.3251<25<25<25<2533.6841.04
Hygroamblystegium tenax26.6638.22<25<2552.6955.03<2531.71<25<2537.3440.38
Leskea polycarpa25.6231.09<25<25<2534.12<25<25<25<25<25<25
Leucodon sciuroides<2529.98<25<25<25<25<25<25<25<25<25<25
Neckera besseri37.1341.25<25<2554.555.63<25<25<25<2532.2843.28
Orthotrichum diaphanum<2540.79<25<25<2528.2<25<25<25<25<25<25
Oxyrrhynchium hians<25<25<25<25<2529.53<25<25<25<25<25<25
Paraleucobryum longifolium<25<25<25<25<25<25<25<25<25<25<25<25
Plagiomnium affine42.0450.67<2526.8653.357.53<25<25<25<25<25<25
Plagiomnium cuspidatum35.4946.35<25<2533.5345.9<25<25<25<25<2527.79
Plagiomnium rostratum40.4451.65<2542.4233.2345.84<25<25<25<25<25<25
Plagiomnium undulatum<25<25<25<25<25<25<25<25<25<25<25<25
Pleurozium schreberi<2532.99<25<25<25<25<25<25<25<25<25<25
Pohlia nutans<2532.63<25<25<25<25<25<25<25<25<25<25
Polytrichastrum formosum<25<25<25<25<25<25<25<25<25<25<25<25
Porella platyphylla<2541.69<25<25<2527.66<25<25<25<25<25<25
Pseudoleskeella nervosa60.5165.03<2526.2749.8954.5<25<25<25<25<2525.43
Pseudoscleropodium purum<2528.06<25<25<2531.29<2529.89<25<2532.2240.05
Rhytidiadelphus squarrosus<2526.56<25<25<2533.78<25<25<25<25<25<25
Rhytidium rugosum<2533.67<25<25<25<25<25<25<25<25<25<25
Schistidium crassipilum<25<25<25<25<25<25<25<25<25<25<25<25
Syntrichia ruralis<25<25<25<25<25<2530.8341.17<25<2557.4259.35
Thamnobryum alopecurum<2531.9<25<25<25<2526.2640.68<25<25<25<25
Thuidium assimile<25<25<2534.2329.7843.24<25<25<25<2532.2844.58
Table
Table 2. Antibacterial activities of moss extracts (inhibition zones in millimetres).
Table 2. Antibacterial activities of moss extracts (inhibition zones in millimetres).
SpeciesExtractMRSAS. aureusS. epidermidisB. subtilisS. pyogenesS. pneumoniaeS. agalactiaeM. catarrhalis
ATCC 43300ATCC 29213ATCC 12228ATCC 6633ATCC 19615ATCC 49619ATCC 13813ATCC 43617
Amblystegium serpensB———————9.0
Brachythecium rutabulumB9.09.0——————
Calliergonella cuspidataA—7.3——————
B—7.0——————
Cirriphyllum piliferumB—————7.0——
Climacium dendroidesA—7.3——————
Dicranum tauricumB—————8.0——
Oxyrrhynchium hiansA8.68.6——————
B—8.0——————
Paraleucobryum longifoliumB9.69.6——11.6———
Plagiomnium affineB———8.0—8.5——
Plagiomnium cuspidatumA11.310.79.09.010.012.010.010.0
B7.67.6——————
Plagiomnium undulatumA7.08.0——————
B—8.0——————
Pseudoscleropodium purumA—7.3——————
Rhytidium rugosumB———7.5—8.0—7.5
Schistidium crassipilumB8.07.0—9.0—11.5—7.7
Table
Table 3. Literature data on the chemistry (C) and bioactivities (B) of the studied species.
Table 3. Literature data on the chemistry (C) and bioactivities (B) of the studied species.
Species (Family)Bioactivity
Abietinella abietina (Hedw.) M. Fleisch.
(Thuidiaceae)		CFatty acids (main components: oleic, palmitic, and linoleic acid) [67];
sterols (sitosterol, stigmasterol, and campesterol) [67,68]
BAntimicrobial effect with MIC (minimum inhibitory concentration) values of 1.25–10 mg/mL against Gram-positive (Staphylococcus aureus, Micrococcus flavus, and Bacillus cereus) and Gram-negative (Escherichia coli and Salmonella typhimurium) bacteria and fungi (Trichoderma viride, Penicillium funiculosum, Penicillium ochrochloron, Aspergillus flavus, A. niger, and A. fumigatus) [69]
Anomodon viticulosus (Hedw.)
Hook. & Taylor
(Thuidiaceae)		CFatty acids (linoleic acid, nonadecanoic acid, palmitic acid, and behenic acid) [37,38]
Atrichum undulatum (Hedw.) P. Beauv.
(Polytrichaceae)		CSterols (major: 24-methylcholesterol and 24-ethyl-22-dehydrocholesterol) [38]; carotenoids (β-carotene, lutein, violaxanthin, and neoxanthin) [38]; fatty acids (major: linoleic acid, α -linolenic acid, palmitic acid, oleic acid, and arachidonic acid) [39]; coumarin glycosides [40]
BAntimicrobial effect of DMSO extracts with MIC values of
0.5–3.0 mg/mL against eight bacterial species (Escherichia coli, Pseudomonas aeruginosa, Salmonella typhimurium, Enterobacter cloacae, Listeria monocytogenes, Bacillus cereus, Micrococcus flavus, and Staphylococcus aureus) [41]; aqueous extract active against Staphylococcus aureus [42]; weak antioxidant activity in vitro [70]
Brachythecium rutabulum (Hedw.) Schimp.
(Brachytheciaceae)		CPolyunsaturated fatty acids [71]
BThe EtOH extract active against the bacteria Micrococcus luteus, Bacillus subtilis, Bacillus cereus, Enterobacter aerogenes, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, Staphylococcus aureus, Salmonella typhimurium, and Streptococcus pneumoniae and the fungi Candida albicans, Cryptococcus albidus, Trichophyton rubrum, Aspergillus niger, and Aspergillus flavus with MIC values of 0.19–1.56 μg/mL [44]; antioxidant activity [50]
Brachytheciastrum velutinum (Hedw.) Ignatov & Huttunen
(Brachytheciaceae)		CPhenolic acids (4-O-caffeoylquinic, 5-O-caffeoylquinic, and caffeic and ellagic acids) and flavonoids (apigenin-7-O-glucoside, luteolin, and apigenin) [43]
Bryum argenteum Hedw.
(Bryaceae)		CMajor flavonoid glycosides in Antarctic B. argenteum samples apigenin and luteolin glucosides and their 6″-malonyl esters, and the
7-O-glucosides of 8-hydroxyapigenin and 8-hydroxyluteolin [45]; luteolin and apigenin content between 0.1 and 0.6 mg/g [46]
BIn vitro antimicrobial effects of different extracts against Bacillus cereus, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, Enterococcus faecalis, Enterobacter aerogenes, and Proteus mirabilis. Highest activity against E. coli and S. aureus (MICs of 30–70 μg/mL) [47]; no activity of different extracts against Staphylococcus aureus, Salmonella pullorum, Phytomonas phaseoli, Candida albicans, Salmonella paratyphi, Micrococcus flavus, Shigella flexneri, Micrococcus rubens, or Streptococcus pyogenes [8]; an EtOH extract exerted antimicrobial activity on Escherichia coli, Bacillus subtilis, Micrococcus luteus, Staphylococcus aureus, Aspergillus niger, Penicilliumo chrochloron, Candida albicans, and Trichophyton mentagrophyes with MICs of 0.10–0.41 mg/mL [48]
Bryum moravicum Podp.
(Bryaceae)		CHigh α-linolenic acid content [72]
BModerate antioxidant activity in vitro [73]
Calliergonella cuspidata (Hedw.) Loeske
(Hypnaceae)		CFatty acids (major: palmitic acid, stearic acid, oleic acid, and linolenic acid [49]
BWeak antioxidant activity in vitro [50]
Ceratodon purpureus (Hedw.) Brid.
(Ditrichaceae)		CFlavonoid (lutelolin) [74]; polyacetylenes [75]; fatty acids (Ω-3 and -6) [38]; five new isopimarane diterpenes—smardaesidins A–E—and two new 20-nor-isopimarane diterpenes—smardaesidins F and G—together with sphaeropsidins A and C–F were isolated from an endophytic fungal strain, Smardaea sp. AZ0432, obtained from Ceratodon purpureus [76]
BA MeOH extract with moderate effect against methicillin-resistant Staphylococcus aureus [59]; moderate antioxidant activity of the EtOH extract, independent from the total phenolic content [77]; sphaeropsidin A and D cytotoxic on different cancer cell lines, and sphaeropsidin A inhibited the migration of metastatic breast adenocarcinoma (MDA-MB-231) cells at subcytotoxic concentration [76]
Climacium dendroides (Hedw.)
F. Weber & D. Mohr(Climaciaceae)		CSterols (major: sitosterol, stigmasterol, and campesterol) [67]; organic acids and flavonoid (apigenin) [51]; chromenone derivatives and flavonoids (kaempferol and quercetin glycosides) [52]
BEtOH extract with weak antiproliferative effect on different animal and human cancer cell lines and remarkable antimicrobial activity against Escherichia coli, Bacillus cereus, and Staphylococcus aureus [51]
Funaria hygrometrica Hedw.
(Funariaceae)		CBracteatin, as the first higher plant pigment in mosses, was isolated from this species [78]
BDifferent extracts had weak antimicrobial activities against Bacillus subtilis, Pseudomonas aeruginosa, and Staphylococcus aureus [79]
Homalothecium lutescens (Hedw.) H. Rob.
(Brachytheciaceae)		CFlavonoids (3′,3″′-binaringenin and the newly discovered 2,3-dihydro 3′,3″′-biapigenin) [80]
BThe essential oil was active against the fungi Candida albicans and Saccharomyces cerevisiae [81]
Homalothecium philippeanum
(Spruce) Schimp.
(Brachytheciaceae)		BMeOH extract had antibacterial activity against Staphylococcus aureus, Escherichia coli, Micrococcus flavus, and Salmonella typhimurium (MICs of 5 mg/mL) and antifungal activity against Aspergillus niger, A. ochraceus, A. versicolor, Penicillium funiculosum, Trichoderma viride, and Candida albicans (MICs of 0.5–2.5 mg/mL) [53]
Leucodon sciuroides (Hedw.) Schwägr.
(Leucodontaceae)		COxylipins (oct-1-en-3-ol, (Z)-octa-1,5-dien-3-ol, (Z)-non-2-enal, (E)-non-2-enal, (Z)-non-3-enal, and 16-(2E,6Z)-nona-2,6-dienal); essential oil with nonanal and heptanal as main constituents [82]
BThe MeOH extract had weak to moderate antimicrobial effect against the bacteria Bacillus subtilis, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Salmonella typhimurium, Staphylococcus aureus, Streptococcus pyogenes, and Mycobacterium smegmatis and the fungi Candida albicans, Rhodotorula rubra, and Kluyveromyces fragilis [83]; essential oil showed activity against Candida albicans [82]
Plagiomnium affine
(Blandow ex Funck) T. J. Kop.
(Mniaceae)		CFlavonoids (apigenin, vitexin [55], isoorientin, isoorientin
3′-O-sophoroside, and isoorientin 3′-O-neohesperidoside [54])
Plagiomnium cuspidatum
(Hedw.) T. J. Kop.
(Mniaceae)		CFlavonoids (saponarine [55]; the 6-C-glucosyl-7-O-glucosides of apigenin, luteolin, and chrysoeriol; and apigenin-7-O-neohesperidoside [56]) and the new dihydrobiflavone 2,3-dihydro-5′-hydroxyamentoflavone, 2,3-dihydro-5′,3′″-dihydroxyamentoflavone, and 2,3-dihydro-5′-hydroxyrobustaflavone [56]
Plagiomnium undulatum (Hedw.) T. J. Kop.
(Mniaceae)		CFlavonoids (the biflavonoids 2,3-dihydro-5′-hydroxyrobustaflavone and 2,3-dihydro-5′-hydroxyamentoflavone; the new 3′″-desoxydicranolomin, 2,3-dihydro-3′″-desoxydicranolomin, and 2,3-dihydro-5′,3′″-dihydroxyrobustaflavone [57]; the flavone di-C-glycosides schaftoside, isoschaftoside, neoschaftoside, neosisoschaftoside, vicenin-2, and a chrysoeriol 6-C-arabinosyl-8-C-hexoside [58]); essential oil with sesquiterpene hydrocarbons, including γ-elemene as major constituent [84]
Pleurozium schreberi (Willd. ex Brid.) Mitt.
Hylocomiaceae		CApigenin and apigenin-7-rhamnoglucoside [85]
BThe MeOH extract had weak to moderate activity against Staphylococcus aureus, methicilline-resistant Staphylococcus aureus, Bacillus subtilis, and Enterococcus faecalis [59]
The MeOH extract was moderately active against Staphylococcus aureus, S. epidermidis, Micrococcus flavus, Bacillus subtilis, Escherichia coli, Enterobacter cloacae, and Salmonella typhimurium (MICs of 10-25 mg/mL) and had strong antifungal activity (MIC of 0.5 mg/mL and minimal bactericidal concentration of 2.5–5.0 mg/mL) against Aspergillus niger, A. ochraceus, A. versicolor, A. flavus, Penicillium funiculosum, Trichoderma viride, and Candida albicans [53]; the EtOH extract had weak antioxidant activities in different test systems [70]
Pohlia nutans (Hedw.) Lindb.
(Bryaceae)		CEssential oil with nonanal and 2E-tetradecen-1-ol
as major constituents [81]
Polytrichastrum formosum
(Hedw.) G. L. Sm.
(Polytrichaceae)		BInsecticidal activity of the hexane extract against Sitophilus granaries [86]
Porella platyphylla (L.) Pfeiff.
(Porellaceae)		CThree new pinguisane-type sesquiterpenes (pinguisanin, pinguisanolide, and β-pinguisenediol) and the previously known deoxopinguisone [60]; a new pinguisanoic acid sesquiterpenoid derivative—methyl 2a-hydroxy-6-oxo-11-pinguisanoate—and a new sacculatane diterpenoid hemiacetal—(5S,9S, 10R,13S)-ll,13-epoxy-8(12),17-sacculatadiene-13β,15ζ-diol[(13S)-15 ζ-hydroxysacculaporellin]—as well as three known pinguisanes (pinguisanin, β-pinguisenediol, and porellapinguisanolide) and the known sacculataneperrottetianal B [61]; flavonoids (isovitexin, saponarin, apigenin-6,8-di-C-glycoside [62], schaftoside, vicenin, and isovitexin [63]); perrottetianal B, phytol, and stigmasterol l [87]
BAntinociceptive effect of the ether extract (main components: pinguisanin and spiropinguisanine) [88]
Pseudoscleropodium purum
(Hedw.) M. Fleisch.(Brachytheciaceae)		CSterols (24-methyl-5-cholestenol, 24-ethyl-5-cholestenol, and
24-ethyl-5,22-cholestadienol) [64], cyclolaudenol, 31-norcyclolaudenol, campesterol, stigmasterol, and β-sitosterol; the triterpenes hopene, 22(29)-hopene, and ursolic acid [65]; essential oil with the major components α-pinene, β-longipinene, and heptanal [66]
Rhytidiadelphus squarrosus
(Hedw.) Warnst.
(Hylocomiaceae)		CSterols (24-methyl-5-cholestenol, 24-ethyl-5-cholestenol, and 24-ethyl-5,22-cholestadienol) [64]; flavonoids (the new biflavone 5′-hydroxyrobusta-flavone and the biflavonoids 5′-hydroxyamentoflavone,5′,3′″-dihydroxyamento-flavone and 2,3-dihydro-5′-hydroxyamentoflavone) [89]
BThe EtOH extract inhibited the growth of Staphylococcus aureus in vitro [89]
Rhytidium rugosum (Hedw.) Kindb.
(Hylocomiaceae)		CThe major compounds of the essential oil were n-hexadecanoic acid, linolenic acid, and cis-9- and cis-12-octadecadienoic acid. In the diethyl ether extract, ethyl oleate and τ-sitosterol were the most abundant [90]
BThe MeOH extract exhibited antibacterial effect on Staphylococcus aureus and Micrococcus flavus (MIC of 5 mg/mL) and antifungal activity against Aspergillus niger, A. ochraceus, A. versicolor, A. flavus, Penicillium funiculosum, Trichoderma viride, and Candida albicans with MIC values of 0.5–2.5 mg/mL [53].

Share and Cite

MDPI and ACS Style

Vollár, M.; Gyovai, A.; Szűcs, P.; Zupkó, I.; Marschall, M.; Csupor-Löffler, B.; Bérdi, P.; Vecsernyés, A.; Csorba, A.; Liktor-Busa, E.; et al. Antiproliferative and Antimicrobial Activities of Selected Bryophytes. Molecules 2018, 23, 1520. https://doi.org/10.3390/molecules23071520

AMA Style

Vollár M, Gyovai A, Szűcs P, Zupkó I, Marschall M, Csupor-Löffler B, Bérdi P, Vecsernyés A, Csorba A, Liktor-Busa E, et al. Antiproliferative and Antimicrobial Activities of Selected Bryophytes. Molecules. 2018; 23(7):1520. https://doi.org/10.3390/molecules23071520

Chicago/Turabian Style

Vollár, Martin, András Gyovai, Péter Szűcs, István Zupkó, Marianna Marschall, Boglárka Csupor-Löffler, Péter Bérdi, Anikó Vecsernyés, Attila Csorba, Erika Liktor-Busa, and et al. 2018. "Antiproliferative and Antimicrobial Activities of Selected Bryophytes" Molecules 23, no. 7: 1520. https://doi.org/10.3390/molecules23071520

APA Style

Vollár, M., Gyovai, A., Szűcs, P., Zupkó, I., Marschall, M., Csupor-Löffler, B., Bérdi, P., Vecsernyés, A., Csorba, A., Liktor-Busa, E., Urbán, E., & Csupor, D. (2018). Antiproliferative and Antimicrobial Activities of Selected Bryophytes. Molecules, 23(7), 1520. https://doi.org/10.3390/molecules23071520

Article Metrics

Back to TopTop